[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D002330:Carmustine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005936:Glucans / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000628:therapy; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008979:Moloney murine leukemia virus; D015002:Yeast, Dried / Q000627:therapeutic use*; D015003:Yeasts / Q000276:immunology
D000276:Adjuvants, Immunologic; D005936:Glucans; D005472:Fluorouracil; D002330:Carmustine
Ulteriore indagine sull'immunopotenziamento della terapia antiblastica sperimentale mediante lieviti inattivati e glucano.